Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Starbucks Corp (SBUX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Starbucks Corp — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.32 (market cap $7.10B), while Starbucks Corp trades at $94.55 (market cap $106.31B). The key difference: Starbucks Corp is far larger — about 15× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Starbucks Corp pays a 2.7% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Starbucks Corp for 190 Days on average.
| IONS | SBUX | |
|---|---|---|
Market Cap | $7.10B | $106.31B |
Volume | 2,027,457 | 6,776,814 |
Sector | Health | Consumer Cyclical |
52-Week High | $86.50 | $108.55 |
52-Week Low | $42.38 | $79.60 |
Typical Hold Time | 0 Days | 190 Days |
Enterprise Value | $6.66B | $125.13B |
Dividend Yield | — | 2.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Starbucks (SBUX) trades at $92.00, down 0.31% on the day, with a bearish technical signal from moving averages. Recent earnings show mixed results, with Q2 2026 beating expectations but Q4 2025 missing. The company is undergoing a strategic reset, closing 250 North American stores amid restructuring charges. Revenue growth remains modest, with 2025 revenue at $37.18 billion and net income of $1.86 billion, though profit margins have compressed from prior years.
The stock presents a cautious outlook with analyst consensus leaning toward a buy rating (47.46% buy) and a $115.50 price target, implying upside. However, risks include execution of store closures, labor relations, and geopolitical tensions in China. Positive cash flow from operations supports dividends, but high debt levels and negative shareholder equity warrant monitoring for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Starbucks Corp
Starbucks Corporation retails, roasts, and provides its own brand of specialty coffee. The Company operates retail locations worldwide and sells whole bean coffees through its sales group, direct response business, supermarkets, and on the world wide web. Starbucks also produces and sells bottled coffee drinks and a line of ice creams.
Read more on SBUX →
